Article
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
2021-02-25
Abstract excerpt
<h4>Rationale</h4> Asthma is associated with chronic changes in the airway epithelium, a key target of SARS-CoV-2. Many epithelial changes are driven by the type 2 cytokine IL-13, but the effects of IL-13 on SARS-CoV-2 infection are unknown. <h4>Objectives</h4> We sought to discover how IL-13 and other cytokines affect expression of genes encoding SARS-CoV-2-associated host proteins in human bronchial epithelial...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- cb8471f0-66b0-5851-8f1a-57d5ad0b1ae7
- DOI
- 10.1101/2021.02.25.432762
